Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma

Neoplasma

Volumn 55, Issue 2, 2008, Pages 127-129

  Stukavec, J ^a   Horak, L ^a   Duchac, V ^a   Jirasek, T ^a   Rakusan, J ^b   Karaskova, M ^b   Pouckova, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Vyzkumny ustav organickych syntez as   (Czech Republic)

Author keywords

Colorectal carcinoma; Photodynamic therapy; Phthalocyanine

Indexed keywords

PHOTOFRIN; PHTHALOCYANINE; ALUMINUM PHTHALOCYANINE DISULFONATE; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; ANIMAL; CELL STRAIN HCT116; COLORECTAL TUMOR; COMPARATIVE STUDY; PHOTOCHEMOTHERAPY;

ANIMALS; COLORECTAL NEOPLASMS; DIHEMATOPORPHYRIN ETHER; HCT116 CELLS; HUMANS; INDOLES; MICE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 48549086167     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ALEXIADES-ARMENAKAS, M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006 Jan-2006 Feb 28; 24: 16-25.
2. JEZEK P, NEKVASIL M, SKOBISOVA E, et al. Experimental photodynamic therapy with MESO-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice. Int J Cancer. 2003 Feb 20; 103: 693-702.
3. KOLAROVA H, NEVRELOVA P, BAJGAR R, et al. In vitro photodynamic therapy on melanoma cell lines with phthalocyanine. Toxicol In Vitro. 2007 Mar; 21: 249-253
4. KRUIJT B, DE BRUIJN HS, van der PLOEG-van den HEUVEL A, et al. Laser speckle imaging of dynamic changes in flow during photodynamic therapy. Lasers Med Sci. 2006 Dec; 21: 208-212
5. MARCUS SL, McINTYRE WR. Photodynamic therapy systems and applications. Expert Opin Emerg Drugs. 2002 Oct; 7: 321-334
6. MOSA M, ZITKO M, POUCKOVA P. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma. Neoplasma. 1997; 44: 178-183
7. NOWIS D, MAKOWSKI M, STOKLOSA T, et al. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol. 2005; 52(2): 339-352 (Pubitemid 41133769)
8. PARK K, LEE JH. Photosensitizer effect of curcumin on UVB-irradiated HaCaT cells through activation of caspase pathways. Oncol Rep. 2007 Mar; 17: 537-540
9. PERVAIZ S, OLIVO M. Art and science of photodynamic therapy. Clin Exp Pharmacol Physiol. 2006 May-2006 Jun 30; 33: 551-556
10. REGEHLY M, GREISH K, RANCAN F, et al. Water-Soluble Polymer Conjugates of ZnPP for Photodynamic Tumor Therapy. Bioconjug Chem. 2007 Mar 21; 18: 494-499.
11. SCHNEIDER R, TIRAND L, FROCHOT C, et al. Recent improvements in the use of synthetic peptides for a selective photodynamic therapy. Anticancer Agents Med Chem. 2006 Sep; 6: 469-488
12. SEITZ G, WARMANN SW, ARMEANU S, et al. In vitro photodynamic therapy of childhood rhabdomyosarcoma. Int J Oncol. 2007 Mar; 30: 615-620
13. STRNAD R, RYSKA M, BELINA F, et al. Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases - preliminary results. Rozhl Chir. 2006 Mar; 85: 124-128
14. YSLAS EI, DURANTINI EN, RIVAROLA VA. Zinc-(II) 2,9,16,23-tetrakis (methoxy) phthalocyanine: Potential photosensitizer for use in photodynamic therapy in vitro. Bioorg Med Chem. 2007 Mar 30.